688062 迈威生物
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(330,597)(782,728)(719,171)(422,403)(514,987)
投资活动产生之现金流量净额(175,789)(509,623)(602,803)12,836(357,221)
筹资活动产生之现金流量净额584,441444,9363,715,810198,9421,155,175
汇率变动对现金及现金等价物的影响141,4032,264(1,006)(1,720)
现金及现金等价物净增加/(减少)78,069(846,011)2,396,100(211,630)281,246
期初现金及现金等价物余额1,643,6332,489,64593,545305,17523,929
期末现金及现金等价物余额1,721,7021,643,6332,489,64593,545305,175